Artificial intelligence in gynecologic oncology: A cautionary look in the Indian context.
2/5 보강
TL;DR
From the perspective of gynecologic oncologists from India, they urge everyone to take a cautionary look at the rapid AI evolution in oncology.
OpenAlex 토픽 ·
Artificial Intelligence in Healthcare and Education
AI in cancer detection
Endometrial and Cervical Cancer Treatments
From the perspective of gynecologic oncologists from India, they urge everyone to take a cautionary look at the rapid AI evolution in oncology.
APA
Sarita Kumari, Rudrika Chandra, Abhinav Tiwari (2026). Artificial intelligence in gynecologic oncology: A cautionary look in the Indian context.. Seminars in oncology, 53(2), 152456. https://doi.org/10.1016/j.seminoncol.2025.152456
MLA
Sarita Kumari, et al.. "Artificial intelligence in gynecologic oncology: A cautionary look in the Indian context.." Seminars in oncology, vol. 53, no. 2, 2026, pp. 152456.
PMID
41494506 ↗
Abstract 한글 요약
Artificial intelligence (AI) is making remarkable strides in the field of oncology. The potential is humongous, but the perils are understated. From the perspective of gynecologic oncologists from India, we urge everyone to take a cautionary look at the rapid AI evolution in oncology.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Quality of Life Measurement in PARP Inhibitor Trials of Epithelial Ovarian Cancer - What Do We Know?
- Foodborne Mycotoxins as Molecular and Epigenetic Carcinogens: Biochemical Mechanisms and Toxicological Implications.
- The RNA-binding protein Quaking is essential for cardiac homeostasis and function by regulating Morf4l2 splicing.
- Briefing on Nitric Oxide a Signal Molecule in Cancer Metastasis and Therapeutic Target.
- Doxorubicin Resistance Reprograms Triple-Negative Breast Cancer Cell Metabolism via the Fatty Acid β-Oxidation (FAO)-CD36 Regulatory Circuit: Relevance of Enhanced FAO on Tumor Cell Invasiveness.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.